These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25617024)

  • 1. Prefrontal cortical dopamine from an evolutionary perspective.
    Lee YA; Goto Y
    Neurosci Bull; 2015 Apr; 31(2):164-74. PubMed ID: 25617024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex.
    Xing B; Li YC; Gao WJ
    Brain Res; 2016 Jun; 1641(Pt B):217-33. PubMed ID: 26790349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress.
    Novick AM; Forster GL; Hassell JE; Davies DR; Scholl JL; Renner KJ; Watt MJ
    Neuropharmacology; 2015 Oct; 97():194-200. PubMed ID: 26056032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What the rodent prefrontal cortex can teach us about attention-deficit/hyperactivity disorder: the critical role of early developmental events on prefrontal function.
    Sullivan RM; Brake WG
    Behav Brain Res; 2003 Nov; 146(1-2):43-55. PubMed ID: 14643458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia.
    Tseng KY; Lewis BL; Lipska BK; O'Donnell P
    Biol Psychiatry; 2007 Oct; 62(7):730-8. PubMed ID: 17207473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.
    Laplante F; Stevenson CW; Gratton A; Srivastava LK; Quirion R
    J Neurochem; 2004 Dec; 91(6):1473-82. PubMed ID: 15584923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemogenetic approach to model hypofrontality.
    Peña ID; Shi WX
    Med Hypotheses; 2016 Aug; 93():113-6. PubMed ID: 27372868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.
    Abi-Dargham A; Moore H
    Neuroscientist; 2003 Oct; 9(5):404-16. PubMed ID: 14580124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP; Katner JS; Nelson DL; Hemrick-Luecke SK; Threlkeld PG; Heiligenstein JH; Morin SM; Gehlert DR; Perry KW
    Neuropsychopharmacology; 2002 Nov; 27(5):699-711. PubMed ID: 12431845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of the mesocortical dopamine system to operate in distinct temporal modes.
    Lapish CC; Kroener S; Durstewitz D; Lavin A; Seamans JK
    Psychopharmacology (Berl); 2007 Apr; 191(3):609-25. PubMed ID: 17086392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex.
    Yang CR; Seamans JK; Gorelova N
    Neuropsychopharmacology; 1999 Aug; 21(2):161-94. PubMed ID: 10432466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress.
    Berridge CW; Mitton E; Clark W; Roth RH
    Synapse; 1999 Jun; 32(3):187-97. PubMed ID: 10340629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pani L; Gessa GL
    Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early stress and chronic methylphenidate cross-sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens.
    Jezierski G; Zehle S; Bock J; Braun K; Gruss M
    J Neurochem; 2007 Dec; 103(6):2234-44. PubMed ID: 17924950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats.
    Boyce PJ; Finlay JM
    Brain Res Dev Brain Res; 2005 May; 156(2):167-75. PubMed ID: 16099303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic depletion in nucleus accumbens impairs mesocortical dopamine activation and cognitive function in rats.
    Laplante F; Zhang ZW; Huppé-Gourgues F; Dufresne MM; Vaucher E; Sullivan RM
    Neuropharmacology; 2012 Nov; 63(6):1075-84. PubMed ID: 22842071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The principal features and mechanisms of dopamine modulation in the prefrontal cortex.
    Seamans JK; Yang CR
    Prog Neurobiol; 2004 Sep; 74(1):1-58. PubMed ID: 15381316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.
    Agneter E; Hoffmann IS; Singer EA; Cubeddu LX
    J Pharmacol Exp Ther; 1994 May; 269(2):470-6. PubMed ID: 8182513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study.
    Slifstein M; van de Giessen E; Van Snellenberg J; Thompson JL; Narendran R; Gil R; Hackett E; Girgis R; Ojeil N; Moore H; D'Souza D; Malison RT; Huang Y; Lim K; Nabulsi N; Carson RE; Lieberman JA; Abi-Dargham A
    JAMA Psychiatry; 2015 Apr; 72(4):316-24. PubMed ID: 25651194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.